Zydus Lifesciences Limited have approved the following special resolutions for: Appointment of Mr. Akhil Monappa (DIN: 09784366) as an Independent Director of the Company for the first term of five consecutive years effective November 29, 2022 and Appointment of Ms. Upasana Kamineni Konidela (DIN: 02781278) as an Independent Director of the Company for the first term of five consecutive years effective November 29, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
982.2 INR | +1.44% | -1.53% | +42.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.51% | 11.83B | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B | |
+9.14% | 4.9B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences Limited Approves Executive Changes